WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2000061757) TUMOR NECROSIS FACTOR HOMOLOGS AND NUCLEIC ACIDS ENCODING THE SAME
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2000/061757    International Application No.:    PCT/US2000/009699
Publication Date: 19.10.2000 International Filing Date: 12.04.2000
Chapter 2 Demand Filed:    27.09.2000    
IPC:
A61K 38/00 (2006.01), C07K 14/47 (2006.01), C07K 14/705 (2006.01), C12N 15/10 (2006.01), C12Q 1/68 (2006.01)
Applicants: GENENTECH, INC. [US/US]; 1 DNA Way, South San Francisco, CA 94080-4990 (US)
Inventors: GODDARD, Audrey; (US).
PAN, James; (US).
YAN, Minhong; (US)
Agent: MARSCHANG, Diane, L.; Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080-4990 (US).
KIDDLE, Simon J. and others; Mewburn Ellis, York House, 23 Kingsway, London WC2B 6HP (GB)
Priority Data:
60/128,849 12.04.1999 US
Title (EN) TUMOR NECROSIS FACTOR HOMOLOGS AND NUCLEIC ACIDS ENCODING THE SAME
(FR) HOMOLOGUES DE FACTEUR DE NECROSE TUMORALE ET ACIDES NUCLEIQUES LES CODANT
Abstract: front page image
(EN)The present invention is directed to novel polypeptides having homology to members of the tumor necrosis factor receptor family and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
(FR)L'invention concerne des polypeptides qui présentent une homologie par rapport à la famille du récepteur de facteur de nécrose tumorale et des molécules d'acides nucléiques codant ces polypeptides. L'invention concerne également des vecteurs et des cellules hôtes renfermant les séquences d'acides nucléiques considérées, des molécules polypeptidiques chimères renfermant les polypeptides décrits en fusionnement avec des séquences polypeptidiques hétérologues, des anticorps qui se lient aux polypeptides décrits, et des procédés relatifs à l'élaboration desdits polypeptides.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CR, CU, CZ, DE, DK, DM, DZ, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, TZ, UA, UG, UZ, VN, YU, ZA, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)